Facing the challenges of bringing medtech to Germany

January 29, 2021
Robotic pipette with test tubes

The NUB reimbursement pathway has been effective in bringing high-cost innovative medical technologies to the German market, but there are challenges. In MedTech Strategist, we assess the funding of medtech through NUBs and outlines the strengths and weaknesses of the NUB pathway.

Related capabilities

Additional contributors